Skip to main content
Top
Published in: Journal of Interventional Cardiac Electrophysiology 1/2016

01-01-2016

Cardiac troponin T in patients with cardiac implantable electronic devices undergoing magnetic resonance imaging

Authors: John V. Higgins, Robert E. Watson Jr, Allan S. Jaffe, Connie Dalzell, Nancy Acker, Joel P. Felmlee, Samuel J. Asirvatham, Yong-Mei Cha, Paul A. Friedman, Suraj Kapa

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 1/2016

Login to get access

Abstract

Purpose

Magnetic resonance imaging (MRI) has been safely performed in many patients with cardiac implantable electronic devices (CIEDs) using institution-specific protocols. A potential risk of MRI is myocardial heating and cardiac injury, which might be detectable with cardiac Troponin (cTn). We evaluated this in patients with CIEDs undergoing MRI.

Methods

Prospective data were collected from 2008 to the present in patients with CIEDs undergoing clinically indicated MRI performed under institutional protocol. Cardiac Troponin T (cTnT) levels were drawn both before and 24–36 h after the procedure. The collective data were retrospectively analyzed.

Results

MRI exams (n = 512) were performed in 398 patients. Of these, there were 348 unique scans with cTnT recorded before and after MRI (median age 68, IQ 56–78; 62 % men). cTnT did not significantly change for the group as a whole (0.00 ± 0.056). There were 22 (6.3 %) exams with cTnT change ≥0.002 ng/mL following MRI (range 0.01–0.09 ng/mL). There were no clinically significant events in these patients directly attributable to MR. There were no significant changes in pacing threshold or impedance in the group with elevated cardiac biomarkers.

Conclusion

There are very few situations where myocardial injury as detected by cTnT in patients undergoing MRI with CIEDs could be detected. No adverse clinical events or functional changes of the device were noted, even in those with increases in cTnT. Our experience supports that MRI can be performed safely for appropriately selected patients under close clinical observation. Proactive monitoring with the present iteration of cardiac biomarkers appears to be of limited utility, but prospective monitoring with high sensitivity assays may be able to detect subclinical myocardial damage.
Literature
1.
go back to reference Roguin, A. (2009). Magnetic resonance imaging in patients with implantable cardioverter-defibrillators and pacemakers. J Am Coll Cardiol, 54(6), 556–557.CrossRefPubMed Roguin, A. (2009). Magnetic resonance imaging in patients with implantable cardioverter-defibrillators and pacemakers. J Am Coll Cardiol, 54(6), 556–557.CrossRefPubMed
2.
go back to reference Kalin, R., & Stanton, M. S. (2005). Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol, 28(4), 326–328.CrossRefPubMed Kalin, R., & Stanton, M. S. (2005). Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol, 28(4), 326–328.CrossRefPubMed
3.
go back to reference Boilson, B. A., Wokhlu, A., Acker, N. G., Felmlee, J. P., Watson, R. E., Jr., Julsrud, P. R., et al. (2012). Safety of magnetic resonance imaging in patients with permanent pacemakers: a collaborative clinical approach. J Interv Card Electrophysiol, 33(1), 59–67.CrossRefPubMed Boilson, B. A., Wokhlu, A., Acker, N. G., Felmlee, J. P., Watson, R. E., Jr., Julsrud, P. R., et al. (2012). Safety of magnetic resonance imaging in patients with permanent pacemakers: a collaborative clinical approach. J Interv Card Electrophysiol, 33(1), 59–67.CrossRefPubMed
4.
go back to reference Friedman, H. L., Acker, N., Dalzell, C., Shen, W. K., Asirvatham, S. J., Cha, Y. M., et al. (2013). Magnetic resonance imaging in patients with recently implanted pacemakers. Pacing Clin Electrophysiol, 36(9), 1090–1095.CrossRefPubMed Friedman, H. L., Acker, N., Dalzell, C., Shen, W. K., Asirvatham, S. J., Cha, Y. M., et al. (2013). Magnetic resonance imaging in patients with recently implanted pacemakers. Pacing Clin Electrophysiol, 36(9), 1090–1095.CrossRefPubMed
5.
go back to reference Higgins, J. V., Gard, J. J., Sheldon, S. H., Espinosa, R. E., Wood, C. P., Felmlee, J. P., et al. (2014). Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads. Pacing Clin Electrophysiol, 37(10), 1284–1290.CrossRefPubMed Higgins, J. V., Gard, J. J., Sheldon, S. H., Espinosa, R. E., Wood, C. P., Felmlee, J. P., et al. (2014). Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads. Pacing Clin Electrophysiol, 37(10), 1284–1290.CrossRefPubMed
6.
go back to reference Naehle, C. P., Kreuz, J., Strach, K., Schwab, J. O., Pingel, S., Luechinger, R., et al. (2011). Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J, 161(6), 1096–1105.CrossRefPubMed Naehle, C. P., Kreuz, J., Strach, K., Schwab, J. O., Pingel, S., Luechinger, R., et al. (2011). Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J, 161(6), 1096–1105.CrossRefPubMed
7.
go back to reference Naehle, C. P., Meyer, C., Thomas, D., Remerie, S., Krautmacher, C., Litt, H., et al. (2008). Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology, 249(3), 991–1001.CrossRefPubMed Naehle, C. P., Meyer, C., Thomas, D., Remerie, S., Krautmacher, C., Litt, H., et al. (2008). Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology, 249(3), 991–1001.CrossRefPubMed
8.
go back to reference Naehle, C. P., Strach, K., Thomas, D., Meyer, C., Linhart, M., Bitaraf, S., et al. (2009). Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol, 54(6), 549–555.CrossRefPubMed Naehle, C. P., Strach, K., Thomas, D., Meyer, C., Linhart, M., Bitaraf, S., et al. (2009). Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol, 54(6), 549–555.CrossRefPubMed
9.
go back to reference Nazarian, S., Hansford, R., Roguin, A., Goldsher, D., Zviman, M. M., Lardo, A. C., et al. (2011). A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med, 155(7), 415–424.PubMedCentralCrossRefPubMed Nazarian, S., Hansford, R., Roguin, A., Goldsher, D., Zviman, M. M., Lardo, A. C., et al. (2011). A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med, 155(7), 415–424.PubMedCentralCrossRefPubMed
10.
go back to reference Sheldon, S. H., Bunch, T. J., Cogert, G. A., Acker, N. G., Dalzell, C. M., Higgins, J. V., et al. (2015). Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads. Heart Rhythm, 12(2), 345–349.CrossRefPubMed Sheldon, S. H., Bunch, T. J., Cogert, G. A., Acker, N. G., Dalzell, C. M., Higgins, J. V., et al. (2015). Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads. Heart Rhythm, 12(2), 345–349.CrossRefPubMed
11.
go back to reference Wilkoff, B. L., Bello, D., Taborsky, M., Vymazal, J., Kanal, E., Heuer, H., et al. (2011). Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm, 8(1), 65–73.CrossRefPubMed Wilkoff, B. L., Bello, D., Taborsky, M., Vymazal, J., Kanal, E., Heuer, H., et al. (2011). Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm, 8(1), 65–73.CrossRefPubMed
12.
go back to reference Roguin, A., Schwitter, J., Vahlhaus, C., Lombardi, M., Brugada, J., Vardas, P., et al. (2008). Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace, 10(3), 336–346.CrossRefPubMed Roguin, A., Schwitter, J., Vahlhaus, C., Lombardi, M., Brugada, J., Vardas, P., et al. (2008). Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace, 10(3), 336–346.CrossRefPubMed
13.
go back to reference Levine, G. N., Gomes, A. S., Arai, A. E., Bluemke, D. A., Flamm, S. D., Kanal, E., et al. (2007). Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation, 116(24), 2878–2891.CrossRefPubMed Levine, G. N., Gomes, A. S., Arai, A. E., Bluemke, D. A., Flamm, S. D., Kanal, E., et al. (2007). Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation, 116(24), 2878–2891.CrossRefPubMed
14.
go back to reference Jung, W., Zvereva, V., Hajredini, B., & Jackle, S. (2012). Safe magnetic resonance image scanning of the pacemaker patient: current technologies and future directions. Europace, 14(5), 631–637.CrossRefPubMed Jung, W., Zvereva, V., Hajredini, B., & Jackle, S. (2012). Safe magnetic resonance image scanning of the pacemaker patient: current technologies and future directions. Europace, 14(5), 631–637.CrossRefPubMed
15.
go back to reference Achenbach, S., Moshage, W., Diem, B., Bieberle, T., Schibgilla, V., & Bachmann, K. (1997). Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J, 134(3), 467–473.CrossRefPubMed Achenbach, S., Moshage, W., Diem, B., Bieberle, T., Schibgilla, V., & Bachmann, K. (1997). Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J, 134(3), 467–473.CrossRefPubMed
16.
go back to reference Roguin, A., Zviman, M. M., Meininger, G. R., Rodrigues, E. R., Dickfeld, T. M., Bluemke, D. A., et al. (2004). Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation, 110(5), 475–482.PubMedCentralCrossRefPubMed Roguin, A., Zviman, M. M., Meininger, G. R., Rodrigues, E. R., Dickfeld, T. M., Bluemke, D. A., et al. (2004). Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation, 110(5), 475–482.PubMedCentralCrossRefPubMed
17.
go back to reference Luechinger, R., Zeijlemaker, V. A., Pedersen, E. M., Mortensen, P., Falk, E., Duru, F., et al. (2005). In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J, 26(4), 376–383.CrossRefPubMed Luechinger, R., Zeijlemaker, V. A., Pedersen, E. M., Mortensen, P., Falk, E., Duru, F., et al. (2005). In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J, 26(4), 376–383.CrossRefPubMed
18.
go back to reference Sommer, T., Naehle, C. P., Yang, A., Zeijlemaker, V., Hackenbroch, M., Schmiedel, A., et al. (2006). Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation, 114(12), 1285–1292.CrossRefPubMed Sommer, T., Naehle, C. P., Yang, A., Zeijlemaker, V., Hackenbroch, M., Schmiedel, A., et al. (2006). Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation, 114(12), 1285–1292.CrossRefPubMed
19.
go back to reference Mollerus, M., Albin, G., Lipinski, M., & Lucca, J. (2008). Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol, 31(10), 1241–1245.CrossRefPubMed Mollerus, M., Albin, G., Lipinski, M., & Lucca, J. (2008). Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol, 31(10), 1241–1245.CrossRefPubMed
20.
go back to reference Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A. S., & Katus, H. A. (2010). Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem, 56(2), 254–261.CrossRefPubMed Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A. S., & Katus, H. A. (2010). Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem, 56(2), 254–261.CrossRefPubMed
21.
go back to reference Higgins, J. V., Sheldon, S. H., Watson, R. E., Jr., Dalzell, C., Acker, N., Cha, Y. M., et al. (2015). “Power-on resets” in cardiac implantable electronic devices during magnetic resonance imaging. Heart Rhythm, 12(3), 540–544.CrossRefPubMed Higgins, J. V., Sheldon, S. H., Watson, R. E., Jr., Dalzell, C., Acker, N., Cha, Y. M., et al. (2015). “Power-on resets” in cardiac implantable electronic devices during magnetic resonance imaging. Heart Rhythm, 12(3), 540–544.CrossRefPubMed
22.
go back to reference Sommer, T., Vahlhaus, C., Lauck, G., von Smekal, A., Reinke, M., Hofer, U., et al. (2000). MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology, 215(3), 869–879.CrossRefPubMed Sommer, T., Vahlhaus, C., Lauck, G., von Smekal, A., Reinke, M., Hofer, U., et al. (2000). MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology, 215(3), 869–879.CrossRefPubMed
23.
go back to reference Langman, D. A., Goldberg, I. B., Finn, J. P., & Ennis, D. B. (2011). Pacemaker lead tip heating in abandoned and pacemaker-attached leads at 1.5 Tesla MRI. J Magn Reson Imaging, 33(2), 426–431.CrossRefPubMed Langman, D. A., Goldberg, I. B., Finn, J. P., & Ennis, D. B. (2011). Pacemaker lead tip heating in abandoned and pacemaker-attached leads at 1.5 Tesla MRI. J Magn Reson Imaging, 33(2), 426–431.CrossRefPubMed
25.
go back to reference Saunders, J. T., Nambi, V., de Lemos, J. A., Chambless, L. E., Virani, S. S., Boerwinkle, E., et al. (2011). Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation, 123(13), 1367–1376.PubMedCentralCrossRefPubMed Saunders, J. T., Nambi, V., de Lemos, J. A., Chambless, L. E., Virani, S. S., Boerwinkle, E., et al. (2011). Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation, 123(13), 1367–1376.PubMedCentralCrossRefPubMed
Metadata
Title
Cardiac troponin T in patients with cardiac implantable electronic devices undergoing magnetic resonance imaging
Authors
John V. Higgins
Robert E. Watson Jr
Allan S. Jaffe
Connie Dalzell
Nancy Acker
Joel P. Felmlee
Samuel J. Asirvatham
Yong-Mei Cha
Paul A. Friedman
Suraj Kapa
Publication date
01-01-2016
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 1/2016
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-015-0064-7

Other articles of this Issue 1/2016

Journal of Interventional Cardiac Electrophysiology 1/2016 Go to the issue